A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19 Meeting Abstract


Authors: Brentjens, R. J.; Hollyman, D.; Weiss, M.; Stefanski, J.; Przybylowski, M.; Bartido, S.; Borquez-Ojeda, O.; Taylor, C.; Heaney, M.; Riviere, I.; Sadelain, M.
Abstract Title: A phase I trial for the treatment of purine analog-refractory chronic lymphocytic leukemia using autologous T cells genetically targeted to the B cell specific antigen CD19
Meeting Title: 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 26
Issue: 15 Suppl.
Meeting Dates: 2008 May 30-Jun 3
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2008-05-20
Start Page: 143s
Language: English
ACCESSION: WOS:000208457400691
DOI: 10.1200/jco.2008.26.15_suppl.3045
PROVIDER: wos
Notes: Meeting Abstract: 3045 -- Source: Wos
Altmetric Score